Skip to main content
Erschienen in: International Urology and Nephrology 8/2019

16.05.2019 | Urology - Original Paper

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy

verfasst von: Dordaneh Sugano, Abhinav Sidana, Amit L. Jain, Brian Calio, Sonia Gaur, Mahir Maruf, Maria Merino, Peter Choyke, Baris Turkbey, Bradford J. Wood, Peter A. Pinto

Erschienen in: International Urology and Nephrology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Index tumor volume (ITV) measured on radical prostatectomy (RP) specimens has been shown to be associated with adverse pathologic and oncologic outcomes. We evaluate the value of ITV calculated from prostate multiparametric MRI (mpMRI) in predicting adverse clinical and pathologic outcomes.

Materials and methods

Data from a prospectively maintained, single-institution database were analyzed for patients who underwent mpMRI prior to RP (2007–2016). Index tumor was defined as a T2-visible lesion with the longest diameter. Adverse pathologic outcomes were extraprostatic extension (EPE), lymph node invasion (LNI), seminal vesicle invasion (SVI), and positive margins (PM). Logistic and Cox proportional hazard regression were used to assess associations with adverse pathology and biochemical recurrence (BCR), respectively.

Results

Of the 455 patients included, EPE, LNI, SVI and PM were present in 23.5%, 6.2%, 5.5% and 15.7% patients, respectively. Patients with adverse pathologic outcomes had larger median ITV. ITV was found to be an independent predictor of EPE (OR 1.22, p = 0.010), LNI (OR 1.39, p = 0.001), and SVI (OR 1.28, p = 0.009), but not PM (OR 1.03, p = 0.522). Combination of ITV and PSA was found to have predictive ability comparable to that of modified Partin tables (EPE:ITV + PSAAUC = 0.71 vs. PartinAUC = 0.71; LNI:ITV + PSAAUC = 0.92 vs. PartinAUC = 0.90, SVI:ITV + PSAAUC = 0.78 vs. PartinAUC = 0.82). 5 year BCR-free survival (median follow-up 24.9 months) was higher for patients with ITV < 2 cc (84.1% vs. 58.5%, p = 0.001). However, ITV was not found to be an independent predictor of BCR (HR 1.69, p = 0.130).

Conclusions

We demonstrate that ITV measured on mpMRI is a predictor of adverse pathologic and clinical outcomes and can aid in preoperative risk assessment.
Literatur
1.
Zurück zum Zitat Knoedler JJ, Karnes RJ, Thompson RH et al (2014) The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 17:144–148CrossRefPubMed Knoedler JJ, Karnes RJ, Thompson RH et al (2014) The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 17:144–148CrossRefPubMed
2.
Zurück zum Zitat Wysock JS, Mendhiratta N, Zattoni F et al (2016) Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results. BJU Int 118:515–520CrossRefPubMed Wysock JS, Mendhiratta N, Zattoni F et al (2016) Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results. BJU Int 118:515–520CrossRefPubMed
3.
4.
Zurück zum Zitat Villers A, Puech P, Mouton D et al (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176:2432–2437CrossRefPubMed Villers A, Puech P, Mouton D et al (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176:2432–2437CrossRefPubMed
5.
Zurück zum Zitat Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology 255:89–99CrossRefPubMedPubMedCentral Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation. Radiology 255:89–99CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Cookson MS, Aus G, Burnett AL et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545CrossRefPubMed Cookson MS, Aus G, Burnett AL et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545CrossRefPubMed
8.
Zurück zum Zitat Meyer CP, Hansen J, Boehm K et al (2016) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol 35(2):199–206CrossRefPubMed Meyer CP, Hansen J, Boehm K et al (2016) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol 35(2):199–206CrossRefPubMed
9.
Zurück zum Zitat Merrill MM, Lane BR, Reuther AM et al (2007) Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 70:294–298CrossRefPubMed Merrill MM, Lane BR, Reuther AM et al (2007) Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 70:294–298CrossRefPubMed
10.
Zurück zum Zitat Jung JW, Lee JK, Hong SK et al (2015) Stratification of patients with intermediate-risk prostate cancer. BJU Int 115:907–912CrossRefPubMed Jung JW, Lee JK, Hong SK et al (2015) Stratification of patients with intermediate-risk prostate cancer. BJU Int 115:907–912CrossRefPubMed
11.
Zurück zum Zitat Beauval JB, Ploussard G, Cabarrou B et al (2016) Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World J Urol 35(8):1191–1197CrossRefPubMed Beauval JB, Ploussard G, Cabarrou B et al (2016) Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World J Urol 35(8):1191–1197CrossRefPubMed
12.
Zurück zum Zitat Somford DM, Hamoen EH, Futterer JJ et al (2013) The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol 190:1728–1734CrossRefPubMed Somford DM, Hamoen EH, Futterer JJ et al (2013) The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol 190:1728–1734CrossRefPubMed
13.
Zurück zum Zitat Pelzer AE, Colleselli D, Bektic J et al (2008) Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference? BJU Int 101:822–825CrossRefPubMed Pelzer AE, Colleselli D, Bektic J et al (2008) Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference? BJU Int 101:822–825CrossRefPubMed
14.
Zurück zum Zitat Nakanishi H, Troncoso P, Babaian RJ (2008) Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater. J Urol 180:2441–2445 (discussion 2445-6) CrossRefPubMed Nakanishi H, Troncoso P, Babaian RJ (2008) Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater. J Urol 180:2441–2445 (discussion 2445-6) CrossRefPubMed
15.
Zurück zum Zitat Chun FK, Briganti A, Jeldres C et al (2007) Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43:536–543CrossRefPubMed Chun FK, Briganti A, Jeldres C et al (2007) Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43:536–543CrossRefPubMed
16.
Zurück zum Zitat Kongnyuy M, Sidana A, George AK et al (2017) Tumor contact with prostate capsule on magnetic resonance imaging: a potential biomarker for staging and prognosis. Urol Oncol 35:30.e1–30.e8CrossRef Kongnyuy M, Sidana A, George AK et al (2017) Tumor contact with prostate capsule on magnetic resonance imaging: a potential biomarker for staging and prognosis. Urol Oncol 35:30.e1–30.e8CrossRef
17.
Zurück zum Zitat Abdollah F, Abdo A, Sun M et al (2013) Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines. Int J Urol 20:405–410CrossRefPubMed Abdollah F, Abdo A, Sun M et al (2013) Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines. Int J Urol 20:405–410CrossRefPubMed
18.
Zurück zum Zitat Briganti A, Gallina A, Nazareno S et al (2013) 374 External validation of the eau guidelines for pelvic lymph node dissection among patients treated with robotic assisted radical prostatectomy. J Urol 189:e151–e152 Briganti A, Gallina A, Nazareno S et al (2013) 374 External validation of the eau guidelines for pelvic lymph node dissection among patients treated with robotic assisted radical prostatectomy. J Urol 189:e151–e152
19.
Zurück zum Zitat Yossepowitch O, Briganti A, Eastham JA et al (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65:303–313CrossRefPubMed Yossepowitch O, Briganti A, Eastham JA et al (2014) Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65:303–313CrossRefPubMed
20.
Zurück zum Zitat Boorjian SA, Karnes RJ, Crispen PL et al (2010) The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol 183:1003–1009CrossRefPubMed Boorjian SA, Karnes RJ, Crispen PL et al (2010) The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol 183:1003–1009CrossRefPubMed
21.
Zurück zum Zitat Chalfin HJ, Dinizo M, Trock BJ et al (2012) Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int 110:1684–1689CrossRefPubMed Chalfin HJ, Dinizo M, Trock BJ et al (2012) Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int 110:1684–1689CrossRefPubMed
22.
Zurück zum Zitat Preston MA, Blute ML (2014) Positive surgical margins after radical prostatectomy: does it matter? Eur Urol 65:314–315CrossRefPubMed Preston MA, Blute ML (2014) Positive surgical margins after radical prostatectomy: does it matter? Eur Urol 65:314–315CrossRefPubMed
23.
Zurück zum Zitat Novara G, Ficarra V, Mocellin S et al (2012) Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 62:382–404CrossRefPubMed Novara G, Ficarra V, Mocellin S et al (2012) Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 62:382–404CrossRefPubMed
24.
Zurück zum Zitat Ho R, Siddiqui MM, George AK et al (2016) Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy. PLoS One 11:e0157313CrossRefPubMedPubMedCentral Ho R, Siddiqui MM, George AK et al (2016) Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy. PLoS One 11:e0157313CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Meng Y, Li H, Xu P et al (2015) Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis. Int J Clin Exp Med 8:22319–22327PubMedPubMedCentral Meng Y, Li H, Xu P et al (2015) Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis. Int J Clin Exp Med 8:22319–22327PubMedPubMedCentral
26.
Zurück zum Zitat Bhindi B, Mamdani M, Kulkarni GS et al (2015) Impact of the U.S. preventive services task force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. J Urol 193:1519–1524CrossRefPubMed Bhindi B, Mamdani M, Kulkarni GS et al (2015) Impact of the U.S. preventive services task force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. J Urol 193:1519–1524CrossRefPubMed
27.
Zurück zum Zitat Banerji JS, Wolff EM, Massman JD et al (2016) Prostate needle biopsy outcomes in the Era of the U.S. preventive services task force recommendation against prostate specific antigen based screening. J Urol 195:66–73CrossRefPubMed Banerji JS, Wolff EM, Massman JD et al (2016) Prostate needle biopsy outcomes in the Era of the U.S. preventive services task force recommendation against prostate specific antigen based screening. J Urol 195:66–73CrossRefPubMed
28.
Zurück zum Zitat Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277CrossRefPubMed Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277CrossRefPubMed
Metadaten
Titel
Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy
verfasst von
Dordaneh Sugano
Abhinav Sidana
Amit L. Jain
Brian Calio
Sonia Gaur
Mahir Maruf
Maria Merino
Peter Choyke
Baris Turkbey
Bradford J. Wood
Peter A. Pinto
Publikationsdatum
16.05.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 8/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02168-4

Weitere Artikel der Ausgabe 8/2019

International Urology and Nephrology 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.